How serious is FDA warning about revolutionary blood-cancer

Dana-Farber Cancer Institute researcher details promise, peril of CAR T-cell therapy, which enlists body’s immune system to fight disease.

FDA investigates CAR-T therapy as causing cancer in rare cases

CAR-T hype faces infrastructure reality check

Eric Smith (@ESmithMDPhD) / X

Archives — Page 5 of 875 — Harvard Gazette

Cancers, Free Full-Text

False claim FDA said cancer treatments cause cancer

Turning the Lens on Hematologic Malignancies - Leading Discoveries Magazine

Revolutionary sickle cell therapy treatments are available. But at over $1 million, confusion over access persists

Myeloma News - Oncology/Hematology

News and Opinions - World Stem Cell Summit